Evidence map›Paper›PMID 32221672›Full record

ReviewAbdominal radiology (New York)2020

Imaging findings in association with altered maternal alpha-fetoprotein levels during pregnancy.

Hassan Aboughalia, Sarah Bastawrous, Margarita V Revzin, Shani S Delaney, Douglas S Katz, Mariam Moshiri

Abstract readReview
PubMed Publisher
In one paragraph

Review in Abdominal radiology (New York), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hassan AboughaliaDepartment of Radiology, University of Washington Medical Center, Seattle, WA, USA.
Sarah BastawrousDepartment of Radiology, University of Washington Medical Center, Seattle, WA, USA.
Margarita V RevzinDepartment of Radiology and Biomedical Imaging, Yale School of Medicine, New Haven, CT, USA.
Shani S DelaneyDivision of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Washington Medical Center, Seattle, WA, USA.
Douglas S KatzDepartment of Radiology, NYU Winthrop Hospital, Mineola, NY, USA.
Mariam MoshiriDepartment of Radiology, University of Washington Medical Center, Seattle, WA, USA. moshiri@uw.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Maternal serum alpha-fetoprotein is a valuable laboratory test used in pregnant women as an indicator to detect certain clinical abnormalities. These can be grouped into four main categories: fetal factors, pregnancy complications, placental abnormalities, and maternal factors. Imaging is an invaluable tool to investigate the various etiologies leading to altered maternal serum alpha-fetoprotein. By reading this article, the radiologist, sonologist, or other health care practitioner should be able to define the probable pathology leading to the laboratory detected abnormal maternal serum levels, thus helping the clinician to appropriately manage the pregnancy and counsel the patient.

Indexed as

Placenta DiseasesPregnancy Complicationsalpha-FetoproteinsFemaleHumansPlacentaPregnancyalpha-FetoproteinsAlpha-fetoproteinFetal congenital abnormalitiesHigh-risk pregnancySecond trimester screening

Identifiers

PMID32221672

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.